Saturday 17 October 2026 Export DH’s income statement to Excel — free account

Definitive Healthcare Corp.

DH Healthcare Health Information Services

Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024. In the quarter to June 2026, revenue fell 9.14%, EPS grew 28.6%, free cash flow grew 21.4% and total debt fell 4.97%, each against the same quarter a year earlier.

1.00 0.00 0.00%

Follow DH

Alert me

Market cap: $144.3M
P/E: 0.0×
Fwd P/E: 0.0×
Dividend yield: —
F-score: 5/9
Altman Z: −1.48
Beneish M: −4.17
Dividend safety: 45/100

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 70.30%

Capital & Financial Ratios $m

Market Cap 144.27

Revenue 232.70

Net Income (234.74)

Free Cash Flow 28.56

Net Debt (22.96)

Current Ratio 1.86

Debt/Equity 0.86

P/E ratio 0.00

Fwd P/E 0.00

P/S ratio 0.45

P/B ratio 0.56

Past 5Y EPS Growth —

This Y EPS Growth (18.87%)

Next Y EPS Growth (4.18%)

Next Y revenue growth 531.48%

Next 5Y EPS Growth (8.31%)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 9.31%

10-year low 10-year high

P/B against its own 10 years 17.29%

10-year low 10-year high

EV/Sales against its own 10 years 8.14%

10-year low 10-year high

EV/FCF against its own 10 years 8.22%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	308	290	181	184
Receivables	59	53	52	31
Inventory	—	—	—	—
Other	—	—	—	—
	394	370	258	240

	2023	2024	2025	Q'26
Payables	6	11	4	5
ST’ Debt	14	14	9	9
Other	—	—	—	—
	171	161	157	129

Compound Annual Growth %

	10y	5y	3y
Sales	—	15.34%	2.75%
Cash Flow	—	18.29%	14.76%
Earnings	—	0.00%	0.00%
Book Value	—	(20.53%)	(36.53%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	56	55	—	—	—
’25	59	61	60	62	242
’24	63	64	63	62	252
’23	59	61	65	66	251
’22	50	55	57	61	223
’21	37	40	43	46	166
’20	—	28	30	34	118

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	12	11	—	—	—
’25	26	9	16	3	54
’24	17	14	19	8	58
’23	15	12	9	5	41
’22	14	15	11	(4)	36
’21	14	8	(1)	4	25
’20	—	14	1	9	23

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	8	9	—	—	—
’25	18	7	13	(2)	37
’24	16	14	19	(3)	46
’23	14	11	9	4	38
’22	13	15	9	(9)	27
’21	10	7	(1)	3	18
’20	—	13	1	8	22

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.32)	(0.05)	—	—	—
’25	(0.95)	(0.07)	(0.14)	(0.09)	(1.30)
’24	(0.08)	(1.81)	(1.12)	(0.51)	(3.54)
’23	(0.11)	(0.08)	(1.50)	(0.09)	(1.79)
’22	(0.09)	(0.05)	(0.03)	0.07	(0.06)
’21	(0.07)	(0.10)	(0.09)	(0.10)	(0.68)
’20	—	(0.08)	(0.07)	(0.11)	(0.34)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	24.66	9.53	5.53	3.19	2.15	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	50.30	30.11	14.03	10.62	5.68
People
People	Employees	—	—	—	—	625	676	974	830	782	686
	Revenue/emp, $m	—	—	—	0.00	0.19	0.25	0.23	0.30	0.32	0.35
Income, $m
Income, $m	Revenue	—	—	—	86	118	166	223	251	252	242
	Gross margin, %	—	—	—	78.23	74.25	75.51	80.86	81.11	78.30	75.88
	EBT	—	—	—	(36)	(53)	(63)	(42)	(308)	(634)	(209)
	EBT margin, %	—	—	—	(42.57)	(44.46)	(37.78)	(18.81)	(122.58)	(251.28)	(86.64)
	Net income	—	0	—	(36)	(53)	(62)	(24)	(290)	(591)	(199)
	Depreciation	—	—	—	36	63	66	66	353	757	269
Per share, $
Per share, $	Revenue	—	—	—	0.57	1.22	1.81	2.20	2.23	2.16	2.26
	Earnings	—	—	—	(0.24)	(0.34)	(0.68)	(0.06)	(1.79)	(3.54)	(1.30)
	Cash flow	—	—	—	0.14	0.24	0.27	0.35	0.37	0.50	0.50
	Capex	—	—	—	(0.01)	(0.01)	(0.07)	(0.08)	(0.03)	(0.11)	(0.16)
	Free cash flow	—	—	—	0.13	0.22	0.20	0.27	0.34	0.39	0.35
	Book value	—	—	—	8.16	12.32	16.32	14.66	10.63	5.21	3.55
	Shares, m	—	—	—	149	97	92	101	113	117	107
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	45.94	45.94	15.12	5.09	4.55	1.90	1.27
	P/B	—	—	—	5.50	5.50	1.67	0.76	0.95	0.79	0.81
	EV/Sales	—	—	—	48.95	48.95	14.42	4.78	4.35	1.71	1.20
	EV/FCF	—	—	—	267.71	267.71	129.61	39.08	28.60	9.43	7.83
Cash, $m
Cash, $m	Operating cash flow	—	—	—	22	23	25	36	41	58	54
	Capex	—	—	—	(2)	(1)	(7)	(8)	(3)	(12)	(17)
	Free cash flow	—	—	—	20	22	18	27	38	46	37
Balance, $m
Balance, $m	Working capital	—	—	—	(34)	(25)	321	273	223	209	101
	Total debt	—	—	—	439	462	271	264	256	243	165
	Net debt	—	—	—	431	437	(117)	(68)	(52)	(47)	(16)
	Shareholders’ equity	—	—	—	1,216	1,196	1,500	1,482	1,199	607	379
Returns, %
Returns, %	ROA	—	—	—	0.00	(2.95)	(0.92)	(0.34)	(10.25)	(28.34)	(15.23)
	ROIC	—	—	—	(0.68)	(0.61)	(1.23)	(1.95)	(17.96)	(79.31)	(38.62)
	ROE	—	—	—	0.00	(4.24)	(1.32)	(0.48)	(15.10)	(45.74)	(28.18)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CSLT Castlight Health, inc.	$332.4M	— (loss-making)	— (loss-making)	−0.86% (below 0%: shrinking)	n/m	+106.49% (above 0%: growing)	66.20%	(5.42%)	Compare
SPOK Spok Holdings, Inc.	$224.5M	17.7×	16.2×	−1.89% (below 0%: shrinking)	−9.09% (below 0%: shrinking)	−2.00% (below 0%: shrinking)	80.47%	15.50%	Compare
AMWL American Well Corporation	$210.6M	— (loss-making)	— (loss-making)	−26.59% (below 0%: shrinking)	n/m	+266.38% (above 0%: growing)	52.95%	(18.36%)	Compare
SY So-Young International Inc. Sponsored ADR	$198.9M	— (loss-making)	12.8×	+40.84% (above 0%: growing)	n/m	−798.37% (below 0%: shrinking)	44.11%	(8.64%)	Compare
OPRX OptimizeRx Corp.	$166.7M	35.4×	23.0×	−29.77% (below 0%: shrinking)	n/m	+89.86% (above 0%: growing)	76.51%	(0.43%)	Compare
DH Definitive Healthcare Corp.	$144.3M	— (loss-making)	— (loss-making)	−9.14% (below 0%: shrinking)	n/m	+21.44% (above 0%: growing)	73.45%	(12.23%)
HCAT Health Catalyst, Inc.	$135.5M	— (loss-making)	— (loss-making)	−12.68% (below 0%: shrinking)	n/m	+64.26% (above 0%: growing)	49.46%	(51.75%)	Compare
LFMD LifeMD, Inc.	$118.6M	— (loss-making)	— (loss-making)	−3.55% (below 0%: shrinking)	n/m	−247.52% (below 0%: shrinking)	88.82%	(15.08%)	Compare
CCLD CareCloud, Inc.	$82.0M	26.4×	12.5×	+16.45% (above 0%: growing)	n/m	+6.15% (above 0%: growing)	45.24%	5.84%	Compare
Median of peers	$182.8M	26.4×	14.5×	−2.72%	—	+35.21%	59.58%	(7.03%)

All 51 Health Information Services stocks →

Definitive Healthcare Corp. (DH) key facts

Concern: Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
Definitive Healthcare Corp. (DH) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, DH traded at $1.00, a market capitalization of $144.3 million.
Return on equity was −28.2% and debt-to-equity 0.86.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −1.48 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.